Narrow search
Showing 1 - 10 of 252
Cover Image
Five-Year Evolution of Drug Prescribing in a University Adult Intensive Care Unit
Carron, Christine; Voirol, Pierre; Eggimann, Philippe; … - In: Applied Health Economics and Health Policy 10 (2012) 5, pp. 355-358
Persistent link: https://www.econbiz.de/10011005058
Cover Image
PleurX Peritoneal Catheter Drainage System for Vacuum-Assisted Drainage of Treatment-Resistant, Recurrent Malignant Ascites: A NICE Medical Technology Guidance
White, Judith; Carolan-Rees, Grace - In: Applied Health Economics and Health Policy 10 (2012) 5, pp. 299-308
The PleurX peritoneal drainage catheter for drainage of malignant ascites in a community setting has been evaluated by the NICE Medical Technologies Evaluation Programme. This article outlines the evidence included in the Sponsor's submission, the independent critique by the External Assessment...
Persistent link: https://www.econbiz.de/10011005059
Cover Image
Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany: Results from Administrative Data Using a Propensity Score-Matching Approach
Baumler, Michael Bumler; Stargardt, Tom; Schreyogg, … - In: Applied Health Economics and Health Policy 10 (2012) 4, pp. 235-248
effective than the other. Abstract: Objective:Objective: The aim of this study was to measure the cost effectiveness of DES … compare the costs and effectiveness of DES and BMS in patients with AMI. Patients with hospital admission after AMI in 2004 … Infarction Mortality Prediction Rules using propensity score matching. After matching, we calculated incremental cost-effectiveness …
Persistent link: https://www.econbiz.de/10011005060
Cover Image
Cost Effectiveness of Prostacyclins in Pulmonary Arterial Hypertension
Roman, Antonio; Barberà, Joan A. Barber; Escribano, Pilar - In: Applied Health Economics and Health Policy 10 (2012) 3, pp. 175-188
no comparison studies, so the final decision must be driven by factors such as efficacy, administration route, safety … profile and economic aspects. Abstract: Objective:Objective: This study provides a cost-effectiveness and cost …-member expert panel. Efficacy was obtained from pivotal clinical trials of ILO, EPO and TRE, the latter used in Spain as a foreign …
Persistent link: https://www.econbiz.de/10011005061
Cover Image
An Application of a Proposed Framework for Formulary Listing in Low-Income Countries: The Case of Côte d'Ivoire
Diaby, Vakaramoko; Lachaine, Jean - In: Applied Health Economics and Health Policy 9 (2011) 6, pp. 389-402
'Ivoire considered severity of disease and cost effectiveness of treatment to be the most significant criteria for priority reimbursement …
Persistent link: https://www.econbiz.de/10011005062
Cover Image
Cost-Effectiveness Analysis of Early versus Non-Early Intervention in Acute Migraine Based on Evidence from the 'Act when Mild' Study
Slof, John - In: Applied Health Economics and Health Policy 10 (2012) 3, pp. 201-215
effectiveness of early versus non-early intervention with almotriptan in acute migraine. Abstract: Methods:Methods: An economic …-early treatment of acute migraine with almotriptan. Incremental cost-effectiveness ratios (ICERs) were determined in terms of QALYs … cost-effectiveness acceptability curves. Abstract: Results:Results: Early treatment has shown to lead to shorter attack …
Persistent link: https://www.econbiz.de/10011005063
Cover Image
The Chinese Healthcare System: Structure, Problems and Challenges
Hougaard, Jens Leth.; Østerdal, Lars Peter. sterdal; Yu, Yi - In: Applied Health Economics and Health Policy 9 (2011) 1, pp. 1-13
We describe the structure and present situation of the Chinese healthcare system and discuss its primary problems and challenges. We discuss problems with inefficient burden sharing, adverse provider incentives and huge inequities, and seek explanations in the structural features of the Chinese...
Persistent link: https://www.econbiz.de/10011005064
Cover Image
Insensitivity to Scope in Contingent Valuation Studies: Reason for Dismissal of Valuations?
Søgaard, Rikke Sgaard; Lindholt, Jes; Gyrd-Hansen, Dorte - In: Applied Health Economics and Health Policy 10 (2012) 6, pp. 397-405
Background:Background: The credibility of contingent valuation studies has been questioned because of the potential occurrence of scope insensitivity, i.e. that respondents do not react to higher quantities or qualities of a good. Abstract: Objective:Objective: The aim of this study was to...
Persistent link: https://www.econbiz.de/10011005065
Cover Image
Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain: The ECOBIM Study
Dilla, Tatiana; Valladares, Amparo; Nicolay, Claudia; … - In: Applied Health Economics and Health Policy 10 (2012) 6, pp. 417-430
Background:Background: Weight management is considered a key therapeutic strategy in type 2 diabetes mellitus. However, little is known about the impact of weight loss or body mass index (BMI) reduction on type 2 diabetes-related healthcare costs. Abstract: Objective:Objective: The aim of this...
Persistent link: https://www.econbiz.de/10011005066
Cover Image
What Explains Willingness to Pay for Smoking-Cessation Treatments - Addiction Level, Quit-Rate Effectiveness or the Opening Bid?
Olsen, Jan Abel.; Røgeberg, Ole J. Rgeberg; Stavem, Knut - In: Applied Health Economics and Health Policy 10 (2012) 6, pp. 407-415
theory, such as quit-rate effectiveness, degree of addiction as measured by the 12-item Cigarette Dependence Scale (CDS-12 …. Differences in quit-rate effectiveness did not matter for people's WTP for the smoking-cessation programme. Addiction, and having … bids, than by variables reflecting the quality (effectiveness) and need (addiction level) for the good in question. While …
Persistent link: https://www.econbiz.de/10011005067